Globus Medical, Inc. (GMED) Stock
GMED Key Statistics
About Globus Medical, Inc.
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
CEO: Keith W. Pfeil. Company website
GMED — Frequently Asked Questions
What is the GMED stock price today?
Globus Medical, Inc. (GMED) trades at $74.08, down 0.11% on the day, as of Sep 20, 2026 15:01 UTC.
What is Globus Medical, Inc.'s market cap?
Globus Medical, Inc. has a market capitalisation of $9.99B, calculated from the live GMED share price and shares outstanding.
What is the P/E ratio of GMED?
GMED trades at a trailing P/E of 19.04, from earnings per share of $3.89 over the last twelve months.
How much revenue does Globus Medical, Inc. make?
Globus Medical, Inc. generated revenue of $3.14B over the trailing twelve months, which puts the stock at 3.18 times sales.
What is the 52-week range for GMED?
GMED has traded between $54.15 and $100.93 over the past 52 weeks, and the last price is 26.6% below that high.
Is Globus Medical, Inc. profitable?
Yes. Globus Medical, Inc. keeps 17.03% of revenue as net income over the trailing twelve months.
What is the analyst price target for GMED?
Wall Street analysts rate GMED Buy, with an average price target of $98.88, 33.5% above the current price.
What sector is Globus Medical, Inc. in?
Globus Medical, Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.
Who is the CEO of Globus Medical, Inc.?
Keith W. Pfeil is the chief executive of Globus Medical, Inc., which employs 6,000 people.
Where can I track GMED in real time?
QFI Terminal shows GMED with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See GMED live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open GMED in Terminal See plans